CIK: 0001600135
Total reported value
$1.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SG7 | Sage Therapeutics INC | Stock-Other | 42.92% | -41.20% | — | |
| 2 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 21.97% | — | -21.18% | |
| 3 | ZFGNUSD | Zafgen INC | Stock-Other | 12.84% | -10.91% | — | |
| 4 | ✓ | Foundation Medicine INC | Stock-Other | 10.90% | — | — | |
| 5 | ✓ | Eleven Biotherapeutics INC | Stock-Other | 6.29% | -0.33% | — | |
| 6 | ✓ | Stock-Other | 5.09% | — | -49.73% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Eleven Biotherapeutics INC | -7.3% | — | Unchanged |
| 2 | ✓ | -14.8% | -49.73% | Trim | |
| 3 | AGIO | Agios Pharmaceuticals INC | -16.1% | -21.18% | Trim |
| 4 | ✓ | Foundation Medicine INC | -17.5% | — | Unchanged |
| 5 | SG7 | Sage Therapeutics INC | — | NEW | New buy |
| 6 | ZFGNUSD | Zafgen INC | — | NEW | New buy |